Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

First study of its kind examines hypoplastic left heart syndrome | TAVR & nickel allergies | LVDF & AFib | New M-TEER data

News You Need to Know Today
First study of its kind examines hypoplastic left heart syndrome | TAVR & nickel allergies | LVDF & AFib | New M-TEER data
Wednesday, September 10, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.

READ MORE >
Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).
Share on Twitter Share on Facebook Share on Linkedin

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

Share on Twitter Share on Facebook Share on Linkedin
Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).
The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.
READ MORE >

TAVR still a safe option for patients with nickel allergies

More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.

READ MORE >
The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.
Share on Twitter Share on Facebook Share on Linkedin

TAVR still a safe option for patients with nickel allergies

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.
More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.
READ MORE >

Exploring the link between left ventricular diastolic function and AFib

Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.

READ MORE >
Agfa patient time line of prior exams and echo reporting in its CVIS at ASE 2023.
Share on Twitter Share on Facebook Share on Linkedin

Exploring the link between left ventricular diastolic function and AFib

Share on Twitter Share on Facebook Share on Linkedin
Agfa patient time line of prior exams and echo reporting in its CVIS at ASE 2023.
Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.
READ MORE >

Why patient selection is so important when performing M-TEER

As mitral transcatheter edge-to-edge repair continues to gain momentum in the United States, a new study of CMS data examines what happens to patient outcomes when the procedure fails.

READ MORE >
MitralClip G4 in the Abbott booth at TCT 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Why patient selection is so important when performing M-TEER

Share on Twitter Share on Facebook Share on Linkedin
MitralClip G4 in the Abbott booth at TCT 2023. Photo by Dave Fornell
As mitral transcatheter edge-to-edge repair continues to gain momentum in the United States, a new study of CMS data examines what happens to patient outcomes when the procedure fails.
READ MORE >

Featured Articles

DanGer Shock update: Impella CP heart pump linked to long-term survival benefit

When patients present with STEMI-related cardiogenic shock, treatment with the Impella CP appears to make a positive impact that lasts for at least a decade.

READ MORE >
The key figure from NEJM publication confirms the survival benefit of Impella CP increases year-over-year. Source: Møller J, et al. Long Term Outcomes of the DanGer Shock Trial. N Engl J Med 2025.
Share on Twitter Share on Facebook Share on Linkedin

DanGer Shock update: Impella CP heart pump linked to long-term survival benefit

Share on Twitter Share on Facebook Share on Linkedin
The key figure from NEJM publication confirms the survival benefit of Impella CP increases year-over-year. Source: Møller J, et al. Long Term Outcomes of the DanGer Shock Trial. N Engl J Med 2025.
When patients present with STEMI-related cardiogenic shock, treatment with the Impella CP appears to make a positive impact that lasts for at least a decade.
READ MORE >

Q&A: Cardiologist explores CMS proposal to cover cardiac ablations performed in ambulatory surgical centers

CMS has proposed a policy shift that would allow cardiac ablation procedures to be performed in ambulatory surgical centers. Arash Aryana, MD, PhD, a veteran cardiac electrophysiologist, explained why he is "extremely encouraged" by this proposal, highlighting several potential benefits. 

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Cardiologist explores CMS proposal to cover cardiac ablations performed in ambulatory surgical centers

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
CMS has proposed a policy shift that would allow cardiac ablation procedures to be performed in ambulatory surgical centers. Arash Aryana, MD, PhD, a veteran cardiac electrophysiologist, explained why he is "extremely encouraged" by this proposal, highlighting several potential benefits. 
READ MORE >

FDA clears single-use, fully disposable endovascular robotic system

The new Liberty System allows users to remotely deliver and manipulate guidewires and catheters during peripheral endovascular procedures.

READ MORE >
Microbot Medical Liberty
Share on Twitter Share on Facebook Share on Linkedin

FDA clears single-use, fully disposable endovascular robotic system

Share on Twitter Share on Facebook Share on Linkedin
Microbot Medical Liberty
The new Liberty System allows users to remotely deliver and manipulate guidewires and catheters during peripheral endovascular procedures.
READ MORE >

In Case You Missed It

Abbott’s dissolving stent picks up a key approval

It's another big victory for Abbott's bioresorbable stent for BTK PAD. 

READ MORE >
The Abbott Esprit BTK everolimus-eluting biosorbable scaffold system for below the knee peripheral artery disease on display at TCT 2024. Photo by Dave FornellTCTn 2024 DF
Share on Twitter Share on Facebook Share on Linkedin

Abbott’s dissolving stent picks up a key approval

Share on Twitter Share on Facebook Share on Linkedin
The Abbott Esprit BTK everolimus-eluting biosorbable scaffold system for below the knee peripheral artery disease on display at TCT 2024. Photo by Dave FornellTCTn 2024 DF
It's another big victory for Abbott's bioresorbable stent for BTK PAD. 
READ MORE >

Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing

When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life. 

READ MORE >
The American Society of Nuclear Cardiology (ASNC) is thanking Taylor Swift for speaking publicly about her father’s successful heart surgery after a nuclear stress test confirmed he had severe coronary artery disease. Taylor appeared on the New Heights podcast hosted by Jason and Travis Kelce to discuss a wide variety of topics, including her newest album, The Life of a Showgirl. It was her first podcast appearance ever, and it has already racked up more than 20 million views on YouTube alone.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology group thanks Taylor Swift for spreading word about nuclear stress testing

Share on Twitter Share on Facebook Share on Linkedin
The American Society of Nuclear Cardiology (ASNC) is thanking Taylor Swift for speaking publicly about her father’s successful heart surgery after a nuclear stress test confirmed he had severe coronary artery disease. Taylor appeared on the New Heights podcast hosted by Jason and Travis Kelce to discuss a wide variety of topics, including her newest album, The Life of a Showgirl. It was her first podcast appearance ever, and it has already racked up more than 20 million views on YouTube alone.
When Taylor Swift speaks, the world listens. And when she recently appeared on a podcast for the very first time, she shared the story of how a nuclear stress test saved her father's life. 
READ MORE >

Exploring the lasting legacy of the STS/ACC TVT Registry

"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry.  "This is not a trial; this is real-world experience."

READ MORE >
Joan Michaels, RN, director of the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) Transcatheter Valve Therapies (TVT) and IMPACT congenital heart registries, explains how TVT has helped reshape cardiology and the heart team approach.
Share on Twitter Share on Facebook Share on Linkedin

Exploring the lasting legacy of the STS/ACC TVT Registry

Share on Twitter Share on Facebook Share on Linkedin
Joan Michaels, RN, director of the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) Transcatheter Valve Therapies (TVT) and IMPACT congenital heart registries, explains how TVT has helped reshape cardiology and the heart team approach.
"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry.  "This is not a trial; this is real-world experience."
READ MORE >

In Other News

America sees ‘concerning’ drop in pediatric radiology workforce, despite rising imaging volumes

The findings come amid reports of a “major” workforce shortage in pediatric radiology, driven by decreased trainee interest in related fellowships, rising clinical volumes and a competitive job market. 

READ MORE >
Hospital for Special Surgery pediatric MRI
Share on Twitter Share on Facebook Share on Linkedin

America sees ‘concerning’ drop in pediatric radiology workforce, despite rising imaging volumes

Share on Twitter Share on Facebook Share on Linkedin
Hospital for Special Surgery pediatric MRI
The findings come amid reports of a “major” workforce shortage in pediatric radiology, driven by decreased trainee interest in related fellowships, rising clinical volumes and a competitive job market. 
READ MORE >

Addiction medicine eager to embrace AI

People with substance use disorders stand to benefit from healthcare AI just like any other patients. But they may have to wait a bit longer than most others since AI has only just begun to emerge in addiction medicine. 

READ MORE >
substance use disorder therapy with AI
Share on Twitter Share on Facebook Share on Linkedin

Addiction medicine eager to embrace AI

Share on Twitter Share on Facebook Share on Linkedin
substance use disorder therapy with AI
People with substance use disorders stand to benefit from healthcare AI just like any other patients. But they may have to wait a bit longer than most others since AI has only just begun to emerge in addiction medicine. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiac ablations in ASCs | Shockwave's new IVL catheter | Clopidogrel resistance | Sex dreams & the heart | AI for stroke risk
Heartflow sues AI rival Cleerly | Another win for opportunistic screening | Predicting TAVR outcomes | Key approvals for Abbott
Is TAVR too common among younger patients? | New-look heart failure device delivers | SCAI to study women in the cath lab
Cardiologist compensation keeps climbing | Investing in robotic tech | Doc agrees to pay $6.7M | Virtual nurses
ASNC speaks to policymakers | New IVL tech impresses | FDA clears high-pressure balloon catheter | RSNA names a new editor
Pacemakers recalled again | Johnson & Johnson makes a move | GLP-1 drugs & AFib | Strokes after PFA | New LAAO data
More recalls announced due to high-risk device | AATS helps surgeons manage a major complication | How guidelines impact care

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …2
    • Page 3
    • Page 4
    • Page 5
    • Current page 6
    • Page 7
    • Page 8
    • Page 9
    • Page 10 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup